Restatement of Previously Issued Financial Statements (Details) - USD ($)	Mar. 31, 2018	Dec. 31, 2017
Prepaid expenses and other assets	$ 969,963	$ 334,603
Total current assets	12,234,278	10,316,804
Property, plant and equipment, at cost net of accumulated depreciation	1,940,263	333,499
Patents	3,107,607
Total other assets	11,109,706	11,973,469
Total noncurrent assets held for sale	87,042,249	80,932,386
Total assets	112,326,496	103,556,158
Accrued expenses	1,926,676	820,458
Derivative and other fair value liabilities	11,469,171	2,307,363
Total current liabilities	37,672,608	97,667,971
Lease payable	1,288,709
Total long-term liabilities	102,355,092	21,310,686
Total liabilities	140,027,700	118,978,657
Common stock, par value $.025, 75,000,000 shares authorized, 2,148,080 and 1,832,372 shares issued and 2,141,393 and 1,830,969 shares outstanding, respectively	33,724	45,770
Common stock to be issued	4,935	90,018
Treasury stock, at cost, 11,500 shares	(28,031)	(28,031)
Additional paid in capital	59,699,039	66,286,763
Accumulated equity (deficit)	(92,728,320)	(85,061,593)
Total shareholders' equity/deficit	(31,749,142)	(18,135,382)
Noncontrolling interest	1,351,415	1,459,407
Total equity (deficit)	(30,397,727)	(16,675,975)
Total liabilities and shareholders' equity	112,326,496	$ 103,556,158
Adjustments [Member]
Prepaid expenses and other assets	464,879
Total current assets	464,879
Property, plant and equipment, at cost net of accumulated depreciation	(1,088,803)
Patents	(1,786,863)
Total other assets	(1,786,863)
Total noncurrent assets held for sale
Total assets	(2,410,786)
Accrued expenses	(1,340,599)
Derivative and other fair value liabilities	288,824
Total current liabilities	(1,051,775)
Lease payable	1,288,709
Total long-term liabilities	1,288,709
Total liabilities	236,935
Preferred Series E stock, cumulative, stated value $100 per share, par value $.001, 300,000 shares authorized, 223,950 and 300,000 shares issued and outstanding, respectively	19,631
Common stock, par value $.025, 75,000,000 shares authorized, 2,148,080 and 1,832,372 shares issued and 2,141,393 and 1,830,969 shares outstanding, respectively	(395,575)
Common stock to be issued	(34,544)
Treasury stock, at cost, 11,500 shares	196,219
Additional paid in capital	4,159,640
Accumulated equity (deficit)	(4,481,142)
Total shareholders' equity/deficit	(555,402)
Noncontrolling interest	(2,111,950)
Total equity (deficit)	(2,667,352)
Total liabilities and shareholders' equity	2,410,786
As Previously Reported [Member]
Prepaid expenses and other assets	505,084
Total current assets	11,769,399
Property, plant and equipment, at cost net of accumulated depreciation	3,029,066
Patents	4,894,470
Total other assets	12,896,569
Total noncurrent assets held for sale	87,042,249
Total assets	114,737,282
Accrued expenses	3,267,275
Derivative and other fair value liabilities	11,180,347
Total current liabilities	38,724,384
Lease payable
Total long-term liabilities	101,066,381
Total liabilities	139,790,764
Preferred Series E stock, cumulative, stated value $100 per share, par value $.001, 300,000 shares authorized, 223,950 and 300,000 shares issued and outstanding, respectively	2,676,892
Common stock, par value $.025, 75,000,000 shares authorized, 2,148,080 and 1,832,372 shares issued and 2,141,393 and 1,830,969 shares outstanding, respectively	429,299
Common stock to be issued	39,479
Treasury stock, at cost, 11,500 shares	(224,250)
Additional paid in capital	55,539,399
Accumulated equity (deficit)	(88,247,178)
Total shareholders' equity/deficit	(31,193,739)
Noncontrolling interest	3,463,365
Total equity (deficit)	(27,730,374)
Total liabilities and shareholders' equity	$ 114,737,282